Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) stock enjoyed a major increase of 11.6% on 5/14/24. The shares closed at $9.89. Moreover, trading volume in this advance was exceptionally high at 218% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 11.9% during the last week.
Current PriceTarget Research Rating
ATNM is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Actinium Pharmaceuticals has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Actinium Pharmaceuticals has a very low Appreciation Score of 1 but a good Power Rating of 77, with the Negative Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment